Cannabielsoin: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
No edit summary |
||
| Line 25: | Line 25: | ||
{{stub}} | {{stub}} | ||
<gallery> | <gallery> | ||
File:Cannabielsoin.png|Cannabielsoin | File:Cannabielsoin.png|Cannabielsoin | ||
File:CBE_3D_BS.png|CBE 3D BS | File:CBE_3D_BS.png|CBE 3D BS | ||
</gallery> | </gallery> | ||
Latest revision as of 19:31, 16 March 2025
Cannabielsoin (CBE) is a cannabinoid found in the Cannabis plant. It is a metabolite of cannabidiol (CBD), with the molecular formula C21H30O2.
Chemistry[edit]
Cannabielsoin is a member of the class of compounds known as cannabinoids, which are a group of active compounds found in the cannabis plant. It is a metabolite of cannabidiol, which means it is produced when cannabidiol is metabolized in the body. The chemical structure of cannabielsoin is similar to other cannabinoids, with a 21-carbon structure and two oxygen atoms.
Pharmacology[edit]
The pharmacological effects of cannabielsoin are not well understood. As a metabolite of cannabidiol, it is possible that it may have similar effects, such as anti-inflammatory and anti-anxiety effects. However, more research is needed to confirm these potential effects and to understand how cannabielsoin interacts with the body's endocannabinoid system.
Research and potential uses[edit]
Research into cannabielsoin is still in its early stages, and much is still unknown about its potential uses. Some studies suggest that it may have anti-inflammatory and anti-anxiety effects, similar to cannabidiol. However, more research is needed to confirm these findings and to explore other potential uses for cannabielsoin.


